
Science
Leukemia and Lymphoma Society Lobbies on Cancer Research Funding
Cancer research lobbying intensifies as the Leukemia and Lymphoma Society spends $140,000 advocating for NIH funding, pediatric cancer bills, and patient access.
Data and News Shaping the Political Landscape

Cancer research lobbying intensifies as the Leukemia and Lymphoma Society spends $140,000 advocating for NIH funding, pediatric cancer bills, and patient access.

ImmunityBio pivots to cancer research lobbying through Continental Strategy as Congress debates NIH funding cuts, joining established advocacy coalitions.

APS spends $263K on lobbying for quantum research, emphasizing its commitment to federal science funding.

gener8tor partners with Michael Best Strategies to focus on critical science and technology lobbying efforts as Congress considers innovation funding.